Tafenoquine
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 350 publications
Acute Hemolytic Anemia Due to Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency Triggered by Helicobacter pylori Quadruple Therapy in a Jehovah's Witness: A Case Report.
Journal: Cureus
Published: February 04, 2026
Resolving haplotypes of the glucose-6-phosphate dehydrogenase gene using long-range polymerase chain reaction and Oxford Nanopore sequencing.
Journal: Biology methods & protocols
Published: November 05, 2025
Suboptimal primaquine adherence in Plasmodium vivax malaria: Evidence from high-burden tribal districts in Odisha.
Journal: Journal of infection and public health
Published: October 10, 2025
Strategic resource allocation for malaria elimination in endemic settings: a systematic review of cost-effectiveness evidence.
Journal: Frontiers in public health
Published: October 03, 2025
Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in Pakistan.
Journal: Malaria journal
Published: October 02, 2025
Moving towards high-dose primaquine or single-dose tafenoquine for Plasmodium vivax treatment in Cambodia: a meeting report from dissemination of results of the EFFORT trial to stakeholders.
Journal: Malaria journal
Published: September 30, 2025
G6PD deficiency in Indonesia: a systematic review and update of prevalence and variant maps in the context of malaria elimination.
Journal: The Lancet regional health. Western Pacific
Published: September 25, 2025
Plasmodium falciparum field isolates drug susceptibility in Mali.
Journal: JAC-antimicrobial resistance
Published: September 12, 2025
Human babesiosis: The past, present and future.
Journal: Expert reviews in molecular medicine
Published: September 05, 2025
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial.
Journal: The Lancet. Infectious diseases
Published: September 04, 2025
Development and Validation of a Stability-Indicating HPLC-UV Assay for Quantification of Tafenoquine Succinate in a Novel Paediatric Antimalarial Formulation.
Journal: Biomedical chromatography : BMC
Published: August 18, 2025
Last Updated: 04/28/2026